Isotretinoin and Psychiatric Illness in Adolescents and Young Adults
| Autor: | Shelly J. Enders, Jason M. Enders |
|---|---|
| Rok vydání: | 2003 |
| Předmět: |
Adult
Psychosis medicine.medical_specialty Adolescent Poison control Risk Assessment Suicide prevention Keratolytic Agents Injury prevention medicine Humans Pharmacology (medical) Young adult Isotretinoin skin and connective tissue diseases Psychiatry Depression (differential diagnoses) MedWatch Clinical Trials as Topic Depression business.industry Mental Disorders medicine.disease Affect business medicine.drug |
| Zdroj: | Annals of Pharmacotherapy. 37:1124-1127 |
| ISSN: | 1542-6270 1060-0280 |
| DOI: | 10.1345/aph.1c415 |
| Popis: | OBJECTIVE: To evaluate the relationship between isotretinoin and psychiatric illness in adolescents and young adults. DATA SOURCES: Primary literature located via MEDLINE (1966–December 2002). Key terms were isotretinoin, depression, psychosis, suicide, and adolescents. DATA SYNTHESIS: Information regarding depression was added to isotretinoin labeling in 1998 following a series of case reports and submitted to the MedWatch system. CONCLUSIONS: Although a causal relationship may exist between isotretinoin and psychiatric illness in adolescents and young adults, this has not been demonstrated in the literature. Until evidence establishes a presence or lack of causality, prescribers should exercise caution when treating adolescents and young adults with isotretinoin. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|